Literature DB >> 7594628

Monocyte aggregation around agarose beads in collagen gels: a 3-dimensional model of early granuloma formation?

G F Franklin1, G Coghill, L McIntosh, I A Cree.   

Abstract

Granulomas consist of organised collections of macrophages showing evidence of activation in response to an agent localised within a tissue. To date, in vitro models of granuloma formation have failed to reproduce the histological appearance of a granuloma, which forms a characteristic three-dimensional structure. The use of 3-D collagen gels allows agarose beads and human mononuclear cells to be suspended together in a milieu which permit the two to interact. The interaction between agarose beads and mononuclear cells produces monocyte-macrophage aggregates within 24 h which resemble an early granuloma. The monocytes show evidence of activation by direct microscopy, electron microscopy and immunohistochemistry. This model should permit the laboratory testing of hypotheses describing granuloma formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594628     DOI: 10.1016/0022-1759(95)00153-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease.

Authors:  Evelyn Guirado; Larry S Schlesinger
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

2.  Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.

Authors:  Evelyn Guirado; Uchenna Mbawuike; Tracy L Keiser; Jesus Arcos; Abul K Azad; Shu-Hua Wang; Larry S Schlesinger
Journal:  MBio       Date:  2015-02-17       Impact factor: 7.867

Review 3.  Assessment of Experimental Techniques That Facilitate Human Granuloma Formation in an In Vitro System: A Systematic Review.

Authors:  Nirosha Ganesan; Steven Ronsmans; Jeroen Vanoirbeek; Peter H M Hoet
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.